Clinical trial
Surgery for Early Lung Cancer With Preoperative Erlotinib (Tarceva): A Clinical…
NCT00462995 · University Health Network, Toronto, Other · Completed
Key facts
| NCT number | NCT00462995 |
|---|---|
| Title | Surgery for Early Lung Cancer With Preoperative Erlotinib (Tarceva): A Clinical Phase II Trial (SELECT) |
| Official title | Surgery for Early Lung Cancer With Preoperative Erlotinib (Tarceva): A Clinical Phase II Trial |
| Acronym | SELECT |
| Lead sponsor | University Health Network, Toronto, Other |
| Collaborators | Hoffmann-La Roche Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non Small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | Erlotinib |
| Enrollment | 25 |
| Start date | May 1, 2006 |
| Primary completion | Jan 1, 2012 |
| Completion | Feb 1, 2012 |
| First posted | Apr 19, 2007 |
| Last update posted | Feb 23, 2018 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: